statistiche ricercatore

Continente	#
NA - Nord America	1.670
AS - Asia	565
EU - Europa	562
SA - Sud America	83
Continente sconosciuto - Info sul continente non disponibili	19
AF - Africa	12
OC - Oceania	5
Totale	2.916

Nazione	#
US - Stati Uniti d'America	1.608
SG - Singapore	206
DE - Germania	141
CN - Cina	129
IT - Italia	94
RU - Federazione Russa	75
HK - Hong Kong	72
VN - Vietnam	70
BR - Brasile	64
UA - Ucraina	58
CA - Canada	52
SE - Svezia	47
IE - Irlanda	43
GB - Regno Unito	33
FR - Francia	28
ID - Indonesia	17
BD - Bangladesh	15
IN - India	13
FI - Finlandia	11
NL - Olanda	10
IQ - Iraq	9
PK - Pakistan	8
AR - Argentina	6
EC - Ecuador	5
KR - Corea	5
MX - Messico	5
ES - Italia	4
BE - Belgio	3
GR - Grecia	3
JP - Giappone	3
MA - Marocco	3
NZ - Nuova Zelanda	3
PL - Polonia	3
SA - Arabia Saudita	3
VE - Venezuela	3
ZA - Sudafrica	3
AU - Australia	2
BY - Bielorussia	2
CL - Cile	2
CO - Colombia	2
DK - Danimarca	2
EU - Europa	2
JO - Giordania	2
KG - Kirghizistan	2
KZ - Kazakistan	2
OM - Oman	2
RO - Romania	2
TR - Turchia	2
AE - Emirati Arabi Uniti	1
AL - Albania	1
BM - Bermuda	1
EG - Egitto	1
ET - Etiopia	1
HN - Honduras	1
HU - Ungheria	1
JM - Giamaica	1
KE - Kenya	1
LB - Libano	1
MO - Macao, regione amministrativa speciale della Cina	1
MU - Mauritius	1
NI - Nicaragua	1
NO - Norvegia	1
NP - Nepal	1
PE - Perù	1
PR - Porto Rico	1
TN - Tunisia	1
TW - Taiwan	1
ZW - Zimbabwe	1
Totale	2.899

Nome	#
Exploration of the lysis mechanisms of leukaemic blasts by chimaeric T-cells	329
Cytokine Induced Killer cells for cell therapy of acute myeloid leukemia: improvement of their immune activity by expression of CD33-specific chimeric receptors	316
Chimeric Antigen Receptors against CD33/CD123 antigens efficiently target primary Acute Myeloid Leukemia cells in vivo	316
Targeting of acute myeloid leukaemia by cytokine-induced killer cells redirected with a novel CD123-specific chimeric antigen receptor	292
Comparison of different suicide-gene strategies for the safety improvement of genetically manipulated T cells	291
Upregulation of adhesion molecules on leukemia targets improves the efficacy of cytotoxic T cells transduced with chimeric anti-CD19 receptor	289
Chimeric antigen receptor: a cell therapy based approach for the treatment of acute myeloid leukemia	288
Targeting of Acute Myeloid Leukemia by Cytokine-Induced Killer Cells Redirected with a Novel CD123-Specific Chimeric Antigen Receptor	288
γ-Catenin-Dependent Signals Maintain BCR-ABL1+ B Cell Acute Lymphoblastic Leukemia	264
Chimeric Antigen Receptor for Specific Targeting of Acute Myeloid Leukemia	243
Totale	2.916

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	70	0	0	0	2	4	1	3	6	4	7	6	37
2022/2023	299	25	87	40	21	25	44	1	22	20	4	7	3
2023/2024	146	4	4	3	10	24	27	24	7	21	0	10	12
2024/2025	306	19	34	6	15	23	14	17	8	41	57	25	47
2025/2026	840	89	30	66	75	131	42	107	41	74	78	41	66
2026/2027	268	23	47	81	117	0	0	0	0	0	0	0	0
Totale													2.916

Bicocca Open Archive